arrow
T

Thomas J. Weber

assistance publique hopitaux paris (aphp)
H指数:30
被引数:5,654

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study
2022-08-0413
PRE
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

Burosumab对X连锁低磷血症成人的持续有益作用: 24周双盲安慰剂对照后24周治疗持续时间的结果

2019-06-04110
OAAI
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

一项随机,双盲,安慰剂对照的3期试验,评估了Anti-FGF23抗体Burosumab在X连锁低磷血症成人中的疗效: 第24周的初步分析

2018-06-26229
OAAI
Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23

使用每月剂量的KRN23延长X连锁低磷血症成人的血清磷校正时间

2015-07-01119
OAAI